Increasing Drug List Prices Show No Correlation with Change in Rebates (2012–2017)
View the Infographic
Major Findings:
- Increasing list prices are not correlated with
changes in rebates, shown with the
horizontal blue line. - List prices for all drugs increased faster than the
rate of inflation. There is no consistent pattern
to the changes in rebates; some increased while
others decreased. - There are prominent cases of higher-than-average
price increases on brand drugs where rebates
stayed the same or declined (ex: Humulin).
